Behcets Disease – Pipeline Review, 2019

Behcets Disease, also alternatively known as Behcet’s Syndrome, refers to a rare disorder that causes the inflammation of blood vessels throughout the body. One of the characteristics of the disease includes the occurrence of signs and symptoms which initially seem unrelated to one another. Some of the symptoms include inflammation of the eyes, mouth sores, genital sores, skin rashes, and lesions. Other affected areas of the body include the brain, the digestive system, and the joints. Behcet’s Disease is considered to be an autoimmune disease and genetic and environmental factors are considered to play a role in the occurrence of the disease.

Some of the diagnostic tools for Behcet’s Disease include blood tests and a pathergy test. For the treatment of Behcet’s Disease, an approach is undertaken where the individual symptoms are treated specifically. For instance, skin creams, gels, and ointments are used for skin and genital sores, mouth rinses are used for mouth sores and eye drops are used for the inflammation of the eyes. Systemic treatments such as corticosteroids for the controlling of the inflammation and medications that suppress or alter the immune system are administered.

Pharmaceutical companies along with various research institutes have been focusing on studying and developing new treatment options for Behcet’s Disease. For instance; Apremilast (CC-10004), which is being studied by CELGENE CORPORATION, is currently in phase-3 clinical trials for A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects with Active Behcet's Disease.

At present, more than 80% of the pipeline candidates for Behcet’s Disease are in the phase-2 and phase-3 stage combined. Majority of the studies are sponsored by industry.

Report Description

The report on ‘Behcet’s Disease – Pipeline Review, 2019’ provides a comprehensive overview of the drugs that are in the R&D pipeline by indication or molecule for Behcet’s Disease. The report provides a thorough analysis of the distribution of the pipeline products by clinical trial stage, indication, company, therapy area and details such as clinical trial stage, sponsor, description on every product in the pipeline. Products in the preclinical and clinical stage along with dormant & discontinued pipeline candidates are included in the report. The report also covers additional insights such as epidemiology overview and current market scenario for Behcet’s Disease.

The report on ‘Behcet’s Disease – Pipeline Review, 2019’, which is built by following a robust research methodology involving primary interviews and desk research, provides a complete overview of the R&D activity and pipeline products to assist companies in developing growth strategies and identifying emerging players.

Report Scope

• Thorough assessment of the pipeline products by areas such as development stage; route of administration; drug class; indication; sponsor; molecule type and drug target
• Comprehensive profiles of the pipeline products with details such as company overview; product description; R&D status; development activities; mechanism of action; molecule type; development stage; indications; funding and route of administration
• Overview of dormant and discontinued pipeline products
• Key insights in relation to the epidemiology of conditions being treated by the pipeline products and overview of the addressable or current market for the pipeline products
• Overview of the latest developments; news articles, press releases, and relevant conferences

Report Methodology

• All pipeline reports are built through the analysis of data primarily collected through credible desk research sources. Secondary research is supplemented by interviews conducted with key opinion leaders.
• Desk research sources includes global and regional clinical trials databases; annual reports, websites, press releases & investor presentations of companies; white papers; news articles; reports published by industry associations; articles/reports published on databases such as NCBI, ResearchGate; internal databases

Reasons to Buy this Report

• Develop effective growth strategies based on a comprehensive overview of the R&D activity and pipeline products for Behcet’s Disease
• Identify emerging players or competition in the market based on pipeline products and develop strategies to counter the emergence of these players
• Identify the focus of leading players in relation to R&D for Behcet’s Disease
• Identify potential companies from a partnership or acquisition point of view based on current synergy in R&D activities or strategies to diversify R&D focus to drive growth in business
• Analyze the reasons behind dormant and discontinued products to make changes in the R&D focus if necessary